101 related articles for article (PubMed ID: 21446203)
1. [Age-specific characteristics of acute myeloid leukemia karyotype].
Gritsaev SV; Martynkevich IS; Martynenko LS; Ivanova MP; Aksenova VIu; Moskalenko MV; Zapreeva IM; Abdulkadyrov KM
Ter Arkh; 2011; 83(1):51-5. PubMed ID: 21446203
[TBL] [Abstract][Full Text] [Related]
2. FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
Ferrara F; Criscuolo C; Riccardi C; Izzo T; Pedata M; Copia C; Vicari L; Tarsitano M; Palmieri S; Pane F
Am J Hematol; 2009 Aug; 84(8):532-5. PubMed ID: 19562748
[No Abstract] [Full Text] [Related]
3. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
4. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
[TBL] [Abstract][Full Text] [Related]
5. [Combined application of multiplex reverse transcription-polymerase chain reaction and karyotype analysis to detection of clonal chromosomal aberrations in acute myeloid leukemia].
Huang L; Li CR; Zhang H; Sun LS; Liu WL; Zhou JF
Ai Zheng; 2007 Sep; 26(9):1029-33. PubMed ID: 17927867
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
7. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical picture (event free survival and overall survival) in childhood acute leukemia patients with immunophenotype and chromosomal abnormalities.
Babusíková O; Sejnová D; Kirschnerová G; Kirsnerová Z; Cáp J
Neoplasma; 2000; 47(6):382-9. PubMed ID: 11263863
[TBL] [Abstract][Full Text] [Related]
10. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
[TBL] [Abstract][Full Text] [Related]
11. Chromosome abnormalities in human acute nonlymphocytic leukemia: relationship to age, sex, and exposure to mutagens.
Rowley JD
Natl Cancer Inst Monogr; 1982; 60():17-23. PubMed ID: 6956808
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
13. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
[TBL] [Abstract][Full Text] [Related]
14. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
[TBL] [Abstract][Full Text] [Related]
15. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of acute myeloid leukemia (AML) for medically non-fit patients].
Fritsch S; Buske C; Wörmann B; Wedding U; Hiddemann W; Spiekermann K
Med Klin (Munich); 2007 Apr; 102(4):324-9. PubMed ID: 17426936
[TBL] [Abstract][Full Text] [Related]
17. Karyotype complexity and prognosis in acute myeloid leukemia.
Stölzel F; Mohr B; Kramer M; Oelschlägel U; Bochtler T; Berdel WE; Kaufmann M; Baldus CD; Schäfer-Eckart K; Stuhlmann R; Einsele H; Krause SW; Serve H; Hänel M; Herbst R; Neubauer A; Sohlbach K; Mayer J; Middeke JM; Platzbecker U; Schaich M; Krämer A; Röllig C; Schetelig J; Bornhäuser M; Ehninger G
Blood Cancer J; 2016 Jan; 6(1):e386. PubMed ID: 26771812
[TBL] [Abstract][Full Text] [Related]
18. Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia.
Schiller GJ; O'Brien SM; Pigneux A; Deangelo DJ; Vey N; Kell J; Solomon S; Stuart RK; Karsten V; Cahill AL; Albitar MX; Giles FJ
J Clin Oncol; 2010 Feb; 28(5):815-21. PubMed ID: 20026800
[TBL] [Abstract][Full Text] [Related]
19. Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype.
Gross M; Mkrtchyan H; Glaser M; Fricke HJ; Höffken K; Heller A; Weise A; Liehr T
Int J Oncol; 2009 Feb; 34(2):417-23. PubMed ID: 19148476
[TBL] [Abstract][Full Text] [Related]
20. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
Bains A; Luthra R; Medeiros LJ; Zuo Z
Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
